SPY387.82-1.64 -0.42%
DIA311.34-1.09 -0.35%
IXIC11,289.65-98.85 -0.87%

Axsome Therapeutics Q1 Loss Widens; Receives No FDA Request for New Trials After New Drug Application for Migraine Treatment

MT Newswires · 05/02/2022 04:07

Please log in to view news